Evotec SE ADR (EVO)
NGS · Common · CUSIP 30050E105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for EVO and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
30050E105
IPO
11/4/2021 · $21.75/share
ADR Ratio
1:.5
Business: Evotec SE is a pharmaceutical company that specializes in drug discovery solutions in the areas of neuroscience, diabetes, pain and inflammation, oncology, infectious diseases, respiratory, and fibrosis.

Company Contact

CEO
Werner Lanthaler
CFO
Enno Spillner
Investor Relations
volker.braun@evotec.com
SEC EDGAR Filings
View filings »